Attention Disturbances
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Test Properties of Lower Quarter Y-Balance Test: Effect of Verbal Instructions and Focus Techniques
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
Impact of Probiotic Supplementation on Cognition and Related Health Outcomes Among Video Gamers
Attention and Achievement: A Mind Wandering Investigation
Oculomotor and Cognitive Rehabilitation Using Visual Feedback in Stroke Patients
Relationship Between Dopaminergic Asymmetric Degeneration and Attentional Resources in Parkinson's Disease.